Literature DB >> 34339073

An overview on the seven pathogenic human coronaviruses.

Mina Mobini Kesheh1, Parastoo Hosseini2,3, Saber Soltani2,3, Milad Zandi2,3.   

Abstract

To date, seven human coronaviruses (HCoVs) have been detected: HCoV-NL63, HCoV-229E, HCoV-HKU1, HCoV-OC43, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and SARS-CoV-2. Four of these viruses, including HCoV-NL63, -229E, -HKU1 and -OC43, usually cause mild-to-moderate respiratory diseases with a seasonal pattern. Since 2000, three new HCoVs have emerged with a significant mortality rate. Although SARS-CoV and MERS-CoV caused an epidemic in some countries, SARS-CoV-2 escalated into a pandemic. All HCoVs can cause severe complications in the elderly and immunocompromised individuals. The bat origin of HCoVs, the presence of intermediate hosts and the nature of their viral replication suggest that other new coronaviruses may emerge in the future. Despite the fact that all HCoVs share similarities in viral replication, they differ in their accessory proteins, incubation period and pathogenicity. This study aims to review these differences between the seven HCoVs.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  HCoV-229E; HCoV-HKU1; HCoV-NL63; HCoV-OC43; MERS-CoV; SARS-CoV; SARS-CoV-2; human coronaviruses

Mesh:

Year:  2021        PMID: 34339073     DOI: 10.1002/rmv.2282

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  8 in total

1.  SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets.

Authors:  Angelo Boccia; Rossella Tufano; Veronica Ferrucci; Leandra Sepe; Martina Bianchi; Stefano Pascarella; Massimo Zollo; Giovanni Paolella
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208

2.  ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV.

Authors:  Milad Zandi
Journal:  Eur Respir J       Date:  2022-02-24       Impact factor: 16.671

Review 3.  Is There a Role for SARS-CoV-2/COVID-19 on the Female Reproductive System?

Authors:  Silvia D'Ippolito; Francesca Turchiano; Amerigo Vitagliano; Gennaro Scutiero; Antonio Lanzone; Giovanni Scambia; Pantaleo Greco
Journal:  Front Physiol       Date:  2022-03-02       Impact factor: 4.566

4.  Comment on "COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality."

Authors:  Ahmad Hosseinzadeh Adli; Sanaz Baghban Rahimi
Journal:  Biomed Pharmacother       Date:  2022-08-01       Impact factor: 7.419

5.  Integrated CRISPR-Cas9 System-Mediated Knockout of IFN-γ and IFN-γ Receptor 1 in the Vero Cell Line Promotes Viral Susceptibility.

Authors:  Suyeon Kim; Aleksandra Nowakowska; Young Bong Kim; Ha Youn Shin
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

6.  One Mutation Away, the Potential Zoonotic Threat - Neocov, Planetary Health Impacts and the Call for Sustainability.

Authors:  Hana Wei Jun Chen; Roy Rillera Marzo; Hooi Chia Tang; Saeid Mezail Mawazi; Mohammad Yasir Essar
Journal:  J Public Health Res       Date:  2022-05-16

7.  Boosting the detection performance of severe acute respiratory syndrome coronavirus 2 test through a sensitive optical biosensor with new superior antibody.

Authors:  Chih-Yen Lin; Wen-Hung Wang; Meng-Chi Li; Yu-Ting Lin; Zih-Syuan Yang; Aspiro Nayim Urbina; Wanchai Assavalapsakul; Arunee Thitithanyanont; Kai-Ren Chen; Chien-Cheng Kuo; Yu-Xen Lin; Hui-Hua Hsiao; Kun-Der Lin; Shang-Yi Lin; Yen-Hsu Chen; Ming-Lung Yu; Li-Chen Su; Sheng-Fan Wang
Journal:  Bioeng Transl Med       Date:  2022-09-16

8.  Ribosome Profiling: A Useful Approach to Discover Hidden Corners of SARS-CoV-2.

Authors:  Milad Zandi; Emad Behboudi; Parisa Zeinali; Saber Soltani; Mohammad Reza Shojaei
Journal:  Cell J       Date:  2022-02       Impact factor: 3.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.